ReviewNeuro-oncology advances
Tumor resection in glioblastoma mouse models: Surgical techniques and translational potential.
Review in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical resection is a cornerstone of glioblastoma (GBM) treatment in patients; yet, it remains underrepresented in preclinical studies with mouse models. This narrative review analyzes the current resection techniques used in mouse GBM studies and evaluates their feasibility, reproducibility and translational relevance. A total of 27 eligible studies were included in the review and categorized by resection method: non-guided biopsy punch, non-guided freehand resection, fluorescence-guided freehand resection (using fluorescent cell lines or dyes), and magnetic resonance imaging (MRI)-guided approaches. While non-guided techniques (biopsy punch or freehand) are commonly employed due to their simplicity and affordability, they lack the precision and adaptability of more advanced methods. Fluorescence-guided resection improves tumor visualization but requires costly equipment and can introduce immunological biases. So-called MRI-guided strategies remain rare, and MRI is not actually used intraoperatively. Despite technically challenging, GBM surgical resection in mice is feasible and several effective techniques are currently available. The systematic implementation of tumor resection in GBM preclinical studies could allow to more closely mimic the human scenario thereby improving the predictive value of GBM animal experiments.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.